Right, let’s dive into Unite Group’s first-half results. The headline? Solid operational performance, strategic portfolio refinement, and a tantalising potential acquisition that could reshape the UK student accommodation landscape. Joe Lister and team are navigating structural demand tailwinds with focus.
Core Earnings Power Shines Through
Unite delivered a robust 15% jump in adjusted earnings to £144.2m for H1 2025. This is the number to watch – stripping out non-cash items and one-offs, it reflects the underlying health of the rental engine. Driving this:
- Like-for-like income growth of 7%: A combination of high occupancy and sustained rental increases.
- Adjusted EPS up 3% to 29.5p: Diluted slightly by the shares issued after last July’s equity raise, but still progressing.
- Dividend hike: The interim payout rises 3% to 12.8p per share, signalling confidence.
Don’t be spooked by the 34% drop in IFRS profit. This largely reflects smaller property valuation gains (£61.1m vs £132.5m in H1 2024) – a normalisation from exceptionally strong prior periods, not an operational weakness. EPRA NTA per share, the cleaner NAV measure, grew 1.4% to 986p.
2025/26 Sales Cycle: Later, But Underpinned
Bookings for the upcoming academic year sit at 88% sold (vs 94% same time last year). Unite attributes this to a return to a more typical, later booking pattern:
- Students increasingly using Clearing post A-level results.
- Some holding off, anticipating late discounts (though Unite doesn’t sound like a discounter).
Fundamental demand drivers remain powerful:
- UK 18-year-old applicants: Up 2% for 2025/26.
- International bounce-back: Student visa applications +19% YoY. UCAS shows +2% international applications overall, with Chinese applicants surging 10%.
- University nominations strong: Covering 56% of beds (57% last year).
Based on current bookings, Unite is confidently reiterating guidance for the full year: Adjusted EPS of 47.5-48.25p (up from 46.6p in 2024), targeting rental growth of 4-5% and occupancy of at least 97%.
Portfolio Strategy: Premium Universities & Partnerships
Unite isn’t just collecting rent; it’s strategically reshaping its estate:
- Russell Group Focus: 93% of the portfolio by value is aligned with these high-tariff universities. 100% of recent acquisitions and the development pipeline target these cities.
- Capital Recycling: Sold 10 non-core properties for £214m (Unite share: £142m), recycling capital into stronger markets.
- University JVs Accelerating: Secured major partnerships:
- Newcastle University (2,000 beds): Planning approved, on-site start expected late 2025.
- Manchester Met (2,300 beds): Framework signed, planning submitted.
- Development Pipeline Power: Off-campus pipeline totals 4,600 beds (£925m cost). On-campus JVs add 4,300 beds. Together, they’re forecast to contribute £90m NOI (Unite share) over the next five years.
The Elephant in the Room (or rather, the Potential Empiric)
The RNS confirms the open secret: Unite made an indicative proposal to acquire Empiric Student Property plc. Why it matters:
- Strategic Fit: Empiric’s portfolio is largely complementary, focused on strong university cities.
- Scale & Synergy: Significant opportunity for earnings accretion and cost savings.
- Product Diversification: Empiric brings a differentiated offer, particularly appealing to returning students – broadening Unite’s market reach.
The key phrase: “There can be no certainty that an offer will be made.” But the fact it’s publicly acknowledged suggests serious intent. This is one to watch closely in the coming months. If it lands, it would be transformative.
Balance Sheet & Outlook: Fuelling Growth
Unite maintains a robust financial position:
- LTV stable at 26% (up from 24% at Dec 2024, reflecting investment spend).
- Net Debt to EBITDA: 5.3x (down from 5.5x at Dec 2024).
- 100% of investment debt fixed: Well-hedged against rate fluctuations. Average cost of debt 3.8%, expected to rise to ~4.1% for FY25.
- Ample liquidity: £824m headroom (cash + undrawn facilities).
The outlook hinges on those powerful structural drivers: growing UK 18-year-old cohort (+11% by 2030), recovering international flows, constrained new PBSA supply (viability challenges persist), and HMO regulation pushing students towards purpose-built options. Unite’s alignment with the strongest universities and its active development/partnership pipeline position it squarely to capitalise.
The Bottom Line
Unite’s H1 delivers precisely what investors want to see: underlying earnings growth, strategic portfolio enhancement, and clear visibility on future drivers via its substantial pipeline. The confirmation of the Empiric approach adds a potential high-growth catalyst. While the sales cycle for 2025/26 is unfolding later, the fundamental demand picture supporting Unite’s premium, well-located portfolio looks as compelling as ever. One to hold, and watch that potential acquisition space.
